首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo
【24h】

Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo

机译:Escin通过下调体内和体外胰腺癌中核因子-κB和核因子-κB调控的基因产物来增强吉西他滨的疗效

获取原文
获取原文并翻译 | 示例
           

摘要

Pancreatic cancer is an aggressive malignancy, which generally develops resistance to chemotherapy. Agents that are safe and can sensitize cancer to chemotherapy are urgently needed. Escin, a natural mixture of triterpene saponins isolated from Aesculus wilsonii Rehd, has been demonstrated to possess anti-cancer activity both in vitro and in vivo. The anti-cancer activity of escin could be, in part, due to the inactivation of nuclear factor-κB (NF-κB). In contrast, chemotherapy including gemcitabine could activate NF-κB and lead to chemoresistance. Here, for the first time, we investigated whether escin, via the inactivation of NF-κB, would potentiate the antitumor activity of gemcitabine in pancreatic cancer.
机译:胰腺癌是一种侵袭性恶性肿瘤,通常会产生对化学疗法的抵抗力。迫切需要安全并且可以使癌症对化疗敏感的药物。 Escin是从欧洲七叶树(Aesculus wilsonii Rehd)分离出的三萜皂苷的天然混合物,已被证明在体外和体内均具有抗癌活性。七叶红素的抗癌活性可能部分归因于核因子-κB(NF-κB)的失活。相反,包括吉西他滨的化学疗法可以激活NF-κB并导致化学耐药性。在这里,我们首次研究了七叶皂苷是否通过灭活NF-κB来增强吉西他滨在胰腺癌中的抗肿瘤活性。

著录项

  • 来源
    《Journal of Cancer Research and Clinical Oncology》 |2012年第5期|p.785-797|共13页
  • 作者单位

    Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, 23 Youzheng Str, Nangang, Harbin, People’s Republic of China;

    Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, 23 Youzheng Str, Nangang, Harbin, People’s Republic of China;

    Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, 23 Youzheng Str, Nangang, Harbin, People’s Republic of China;

    Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, 23 Youzheng Str, Nangang, Harbin, People’s Republic of China;

    Department of Pancreatic and Biliary Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, 23 Youzheng Str, Nangang, Harbin, People’s Republic of China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Pancreatic cancer; Escin; Gemcitabine; Nuclear factor-κB;

    机译:胰腺癌;埃斯汀;吉西他滨;核因子-κB;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号